Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Svirydenka, A"'
Autor:
Nilica, Bernhard, Svirydenka, Anna, Fritz, Josef, Bayerschmidt, Steffen, Kroiss, Alexander, Gruber, Leonhard, Virgolini, Irene Johanna
Publikováno v:
In Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) May-June 2022 41(3):138-145
Autor:
Colin G. Miller, Henning Grønbæk, Irene Virgolini, Andreas Kjaer, Pierre Terve, Shadfar Bahri, Peter Iversen, Hanna Svirydenka, Thomas Rohban, Sandy McEwan
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background 68Ga-satoreotide trizoxetan is a novel somatostatin receptor antagonist exhibiting higher tumour-to-background ratios and sensitivity compared to 68Ga-DOTATOC. This randomised, 2 × 3 factorial, phase II study aimed to confirm the
Externí odkaz:
https://doaj.org/article/4c8b1bb0808c480fadaf97e8afe9d6a7
Publikováno v:
In PET Clinics July 2021 16(3):365-373
Autor:
Edwin E. G. W. ter Voert, Hanna Svirydenka, Julian Müller, Anton S. Becker, Miroslav Balaz, Vissarion Efthymiou, Claudia Irene Maushart, Gani Gashi, Christian Wolfrum, Matthias J. Betz, Irene A. Burger
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Background Positron emission tomography (PET) is increasingly applied for in vivo brown adipose tissue (BAT) research in healthy volunteers. To limit the radiation exposure, the injected 18F-FDG tracer dose should be as low as possible. With
Externí odkaz:
https://doaj.org/article/9e6fd289156846fe868bb4a91518b05b
Autor:
Steffen Bayerschmidt, Christian Uprimny, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica, Hanna Svirydenka, Clemens Decristoforo, Elisabeth von Guggenberg, Wolfgang Horninger, Irene Johanna Virgolini
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1191 (2021)
Background: 68Ga-PSMA-11 PET/CT is a promising method for the assessment of local recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the diagnostic performance of early 68Ga-PSMA-11 PET imaging in comparison to 6
Externí odkaz:
https://doaj.org/article/6f2e62fdead3446ba96e4bab33499071
Autor:
Margarida Rodrigues, Kevin-Klaus Winkler, Hanna Svirydenka, Bernhard Nilica, Christian Uprimny, Irene Virgolini
Publikováno v:
Life, Vol 11, Iss 3, p 198 (2021)
Peptide receptor radionuclide therapy (PRRT) has been recognized as a promising therapy against neuroendocrine tumors (NETs). The use of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in NETs has been a matter of controversy. The
Externí odkaz:
https://doaj.org/article/9080fc386e8c44d9a234a29b0453b440
Autor:
Leonhard Gruber, Steffen Bayerschmidt, Josef Fritz, Irene Virgolini, Bernhard Nilica, Anna Svirydenka, Alexander Kroiss
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 41:138-145
Resumen Introduccion La nefrotoxicidad y la hematotoxicidad despues de la terapia con peptidos marcados con radionuclidos (PRRT) se han descrito en multiples estudios usando diferentes actividades acumulativas, numero de ciclos o peptidos marcados co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac2a90eb9dae2452b27960ad4dc9cff
https://doi.org/10.1016/j.remn.2021.03.004
https://doi.org/10.1016/j.remn.2021.03.004
Autor:
Thomas Rohban, Henning Grønbæk, Colin G. Miller, Sandy McEwan, Andreas Kjaer, Pierre Terve, Hanna Svirydenka, Irene Virgolini, Shadfar Bahri, Peter Iversen
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
EJNMMI Research
Miller, C G, Grønbæk, H, Virgolini, I, Kjaer, A, Terve, P, Bahri, S, Iversen, P, Svirydenka, H, Rohban, T & McEwan, S 2021, ' A novel read methodology to evaluate the optimal dose of 68 Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours : a phase II clinical trial ', EJNMMI Research, vol. 11, no. 1, 84, pp. 1-11 . https://doi.org/10.1186/s13550-021-00819-1
Miller, C G, Grønbæk, H, Virgolini, I, Kjaer, A, Terve, P, Bahri, S, Iversen, P, Svirydenka, H, Rohban, T & McEwan, S 2021, ' A novel read methodology to evaluate the optimal dose of 68 Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours : a phase II clinical trial ', EJNMMI research, vol. 11, no. 84, 84 . https://doi.org/10.1186/s13550-021-00819-1
EJNMMI Research
Miller, C G, Grønbæk, H, Virgolini, I, Kjaer, A, Terve, P, Bahri, S, Iversen, P, Svirydenka, H, Rohban, T & McEwan, S 2021, ' A novel read methodology to evaluate the optimal dose of 68 Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours : a phase II clinical trial ', EJNMMI Research, vol. 11, no. 1, 84, pp. 1-11 . https://doi.org/10.1186/s13550-021-00819-1
Miller, C G, Grønbæk, H, Virgolini, I, Kjaer, A, Terve, P, Bahri, S, Iversen, P, Svirydenka, H, Rohban, T & McEwan, S 2021, ' A novel read methodology to evaluate the optimal dose of 68 Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours : a phase II clinical trial ', EJNMMI research, vol. 11, no. 84, 84 . https://doi.org/10.1186/s13550-021-00819-1
Background 68Ga-satoreotide trizoxetan is a novel somatostatin receptor antagonist exhibiting higher tumour-to-background ratios and sensitivity compared to 68Ga-DOTATOC. This randomised, 2 × 3 factorial, phase II study aimed to confirm the optimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d254e7679d4aa8dbac9338fa8185578
https://doaj.org/article/4c8b1bb0808c480fadaf97e8afe9d6a7
https://doaj.org/article/4c8b1bb0808c480fadaf97e8afe9d6a7
Autor:
ter Voert, Edwin E. G. W.1,2 (AUTHOR) Edwin.terVoert@usz.ch, Svirydenka, Hanna1,3 (AUTHOR), Müller, Julian1 (AUTHOR), Becker, Anton S.4,5 (AUTHOR), Balaz, Miroslav4 (AUTHOR), Efthymiou, Vissarion4 (AUTHOR), Maushart, Claudia Irene6,7 (AUTHOR), Gashi, Gani6,7 (AUTHOR), Wolfrum, Christian4 (AUTHOR), Betz, Matthias J.6,7 (AUTHOR), Burger, Irene A.1,8 (AUTHOR)
Publikováno v:
EJNMMI Research. 1/23/2020, Vol. 10 Issue 1, p1-10. 10p.
Autor:
Hanna Svirydenka, Christian Uprimny, Bernhard Nilica, Elisabeth von Guggenberg, Lisa-Maria Rossetti, Irene Virgolini
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 41:S26-S28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9718d73dfff77bc31d05ff89e2f2a05
https://doi.org/10.1016/j.remn.2021.03.008
https://doi.org/10.1016/j.remn.2021.03.008